160 related articles for article (PubMed ID: 31509353)
21. Payer perceptions of the use of real-world evidence in oncology-based decision making.
Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
[No Abstract] [Full Text] [Related]
22. Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma.
Yun HJ; Kim HJ; Kim SY; Lee YS; Lim CY; Chang HS; Park CS
Front Endocrinol (Lausanne); 2021; 12():585364. PubMed ID: 33746898
[TBL] [Abstract][Full Text] [Related]
23. Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
Kim YY; Oh SJ; Chun YS; Lee WK; Park HK
PLoS One; 2018; 13(7):e0200100. PubMed ID: 29979736
[TBL] [Abstract][Full Text] [Related]
24. Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board.
Kim MS; Park HY; Kho BG; Park CK; Oh IJ; Kim YC; Kim S; Yun JS; Song SY; Na KJ; Jeong JU; Yoon MS; Ahn SJ; Yoo SW; Kang SR; Kwon SY; Bom HS; Jang WY; Kim IY; Lee JE; Jeong WG; Kim YH; Lee T; Choi YD
Transl Lung Cancer Res; 2020 Jun; 9(3):507-514. PubMed ID: 32676314
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Watson for oncology and clinicians' treatment recommendations for patients with breast cancer in Korea: A single center experience.
Park H; Kim KE; Choi YJ; Kim H; Kim DH; Kim KY; Kim JY; Bae SH; Yoon JA; Kang T
Indian J Cancer; 2023; 60(2):211-216. PubMed ID: 37530243
[TBL] [Abstract][Full Text] [Related]
26. Hemispheric activation differences in novice and expert clinicians during clinical decision making.
Hruska P; Hecker KG; Coderre S; McLaughlin K; Cortese F; Doig C; Beran T; Wright B; Krigolson O
Adv Health Sci Educ Theory Pract; 2016 Dec; 21(5):921-933. PubMed ID: 26530736
[TBL] [Abstract][Full Text] [Related]
27. Concordance Study in Hepatectomy Recommendations Between Watson for Oncology and Clinical Practice for Patients with Hepatocellular Carcinoma in China.
Zhang W; Qi S; Zhuo J; Wen S; Fang C
World J Surg; 2020 Jun; 44(6):1945-1953. PubMed ID: 32020325
[TBL] [Abstract][Full Text] [Related]
28. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
[TBL] [Abstract][Full Text] [Related]
29. Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer.
Xu F; Sepúlveda MJ; Jiang Z; Wang H; Li J; Liu Z; Yin Y; Roebuck MC; Shortliffe EH; Yan M; Song Y; Geng C; Tang J; Purcell Jackson G; Preininger AM; Rhee K
JCO Clin Cancer Inform; 2020 Sep; 4():824-838. PubMed ID: 32970484
[TBL] [Abstract][Full Text] [Related]
30. Artificial intelligence in urologic oncology: the actual clinical practice results of IBM Watson for Oncology in South Korea.
Park T; Gu P; Kim CH; Kim KT; Chung KJ; Kim TB; Jung H; Yoon SJ; Oh JK
Prostate Int; 2023 Dec; 11(4):218-221. PubMed ID: 38196551
[TBL] [Abstract][Full Text] [Related]
31. "A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.
Hamilton JG; Genoff Garzon M; Westerman JS; Shuk E; Hay JL; Walters C; Elkin E; Bertelsen C; Cho J; Daly B; Gucalp A; Seidman AD; Zauderer MG; Epstein AS; Kris MG
J Oncol Pract; 2019 Apr; 15(4):e277-e288. PubMed ID: 30689492
[TBL] [Abstract][Full Text] [Related]
32. Concordance Between Watson for Oncology and Multidisciplinary Teams in Colorectal Cancer: Prognostic Implications and Predicting Concordance.
Mao C; Yang X; Zhu C; Xu J; Yu Y; Shen X; Huang Y
Front Oncol; 2020; 10():595565. PubMed ID: 33425748
[TBL] [Abstract][Full Text] [Related]
33. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
34. Artificial Intelligence-Driven Oncology Clinical Decision Support System for Multidisciplinary Teams.
Lee K; Lee SH
Sensors (Basel); 2020 Aug; 20(17):. PubMed ID: 32825296
[TBL] [Abstract][Full Text] [Related]
35. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
[TBL] [Abstract][Full Text] [Related]
36. Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
Malone DC; Brown M; Hurwitz JT; Peters L; Graff JS
Value Health; 2018 Mar; 21(3):326-333. PubMed ID: 29566840
[TBL] [Abstract][Full Text] [Related]
37. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
38. How Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
Bieber C; Nicolai J; Gschwendtner K; Müller N; Reuter K; Buchholz A; Kallinowski B; Härter M; Eich W
J Cancer Educ; 2018 Jun; 33(3):708-715. PubMed ID: 27966192
[TBL] [Abstract][Full Text] [Related]
39. Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence.
Oreja-Guevara C; Brownlee W; Celius EG; Centonze D; Giovannoni G; Hodgkinson S; Kleinschnitz C; Havrdova EK; Magyari M; Selchen D; Vermersch P; Wiendl H; Van Wijmeersch B; Salloukh H; Yamout B
Mult Scler Relat Disord; 2023 Jan; 69():104459. PubMed ID: 36565573
[TBL] [Abstract][Full Text] [Related]
40. The first steps in the evaluation of a "black-box" decision support tool: a protocol and feasibility study for the evaluation of Watson for Oncology.
Keikes L; Medlock S; van de Berg DJ; Zhang S; Guicherit OR; Punt CJA; van Oijen MGH
J Clin Transl Res; 2018 Dec; 3(Suppl 3):411-423. PubMed ID: 30873490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
